145 results
Page 3 of 8
8-K
EX-99.1
s8x1wpnqhokenkhadz
5 Aug 21
Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
4:27pm
8-K
EX-99.2
z2pylsm2
5 Aug 21
Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
4:27pm
8-K
EX-99.1
3onyamlu bn
2 Aug 21
Lumos Pharma Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
9:22am
8-K
EX-99.1
nq0t7c9g
21 Jul 21
Lumos Pharma Announces Clinical Updates
8:33am
8-K
EX-99.1
9ki likog
5 May 21
Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
4:28pm
8-K
EX-99.2
hwur 3fjrhag
5 May 21
Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
4:28pm
8-K
EX-99.1
ew4j2r9u6fi1od0p
21 Apr 21
Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned Succession
4:36pm
8-K
EX-99.2
44imlvr
9 Mar 21
Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
4:26pm
8-K
EX-99.1
6wv5 akmks17cq
9 Mar 21
Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
4:26pm
8-K
EX-99.1
qzlwpdwdpoj 45o9z2cu
4 Mar 21
Other Events
9:09am
424B5
ljzcgwgh6v uci
30 Dec 20
Prospectus supplement for primary offering
4:36pm
8-K
EX-99.2
6di79obmmt9zaryec e3
10 Nov 20
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
4:31pm
8-K
EX-99.1
e5f6hq kx
10 Nov 20
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
4:31pm
8-K
EX-99.1
jdyu o338n
13 Aug 20
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:36pm